Menu Back toS25-Let-s-Talk-a-Lot-About-What-Future-Shape-of-Ideal-Collaboration-to-Promote-Life-Science-Field-Is

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe


[S25] Let’s Talk a Lot About What Future Shape of Ideal Collaboration to Promote Life Science Field Is

Session Chair(s)

Yasushi  Okuno, PhD

Yasushi Okuno, PhD

  • Professor,Department of Biomedical Data Intelligence
  • Graduate School of Medicine,Kyoto University, Japan
Japan industries advancement and related innovation has been promoted by industry-academia-government collaboration in each business segment for 50 years. In the world, an innovation invented and developed in one area is applied in other industries in recent years, has become an important driving force of further promoting approach. In the life sciences field including pharmaceuticals and healthcare, the development and application of artificial intelligence and digital technology has advanced like other industries. The Life Intelligence Consortium (LINC), consists of approximately 100 AI/IT companies, pharmaceutical companies, and academia with working period of 4 years from November 2016, has been established to promote innovative approach using AI for more than 30 areas from target search to clinical development, post marketing safety measures, prevention and preemptive medicine. This time, the session will provide an opportunity to thoroughly discuss the progress and future of LINC activities, and key to success in industry-academiagovernment collaboration in life sciences area.

Speaker(s)

Yasushi  Okuno, PhD

Pharmaceutical Innovation Aimed by the AI Consortium “LINC”

Yasushi Okuno, PhD

  • Professor,Department of Biomedical Data Intelligence
  • Graduate School of Medicine,Kyoto University, Japan
Rika  Okamoto, PhD

AI Development on Medicine Development and Post Marketing Safety Measures

Rika Okamoto, PhD

  • Program-Specific Associate Professor, Department of Biomedical Data Intelligence
  • Graduate School of Medicine,Kyoto University , Japan
Yusuke  Sugiura, MSc

AI for Pharmacovigilance ~ Can We Work on This Project as Team “All Japan”?

Yusuke Sugiura, MSc

  • Kyowa Kirin Co., Ltd., Japan
Rika  Abe, RPh

Challenges of Using Medical and Scientific Information by AI in Japan - Seek Solutions through the AI Consortium “LINC”

Rika Abe, RPh

  • Partnership-Promotion Coordinator, Medical Sciences Innovation Hub Program
  • RIKEN, Japan